Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:

Content type

Project (27)


Australia (1)
Austria (6)
Belgium (21)
Burkina Faso (1)
Czech Republic (3)
Denmark (9)
Finland (9)
France (19)
Gabon (1)
Germany (25)
Greece (1)
Hungary (1)
Ireland (3)
Israel (1)
Italy (17)
Luxembourg (6)
Netherlands (27)
Norway (1)
Poland (1)
Portugal (1)
Senegal (1)
Slovenia (3)
Spain (13)
Sweden (16)
Switzerland (16)
United Kingdom (29)
United States (11)

Advanced search

Search projects and results

Results 1 - 10 of 27
12 3 > 
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
ID: 115916
Start date: 2016-04-01, End date: 2019-03-31
The current nosology of neuropsychiatric disorders allows for a pragmatic approach to treatment choice, regulation and clinical research. However, without a biological rationale for these disorders, drug development has dramatically stagnated in the past decades. In a...
Programme: H2020-EU.
Record Number: 209457
Last updated on: 2017-05-17
European Quality In Preclinical Data
ID: 777364
Start date: 2017-10-01, End date: 2020-09-30
Pharmaceutical industry, as well as basic science, depend on robust data and scientific rigor as key drivers for decision making, patent strength and time-to-market, which in turn will determine knowledge gain and availability of new treatments to patients. Recent publications...
Programme: H2020-EU.
Record Number: 211612
Last updated on: 2017-08-22
Liver Investigation: Testing Marker Utility in Steatohepatitis
ID: 777377
Start date: 2017-11-01, End date: 2022-10-31
Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liver Disease (NAFLD) is an increasingly common cause of advanced liver disease that is characterized by substantial...
Programme: H2020-EU.
Record Number: 212225
Last updated on: 2017-10-31
PERtussIS COrrelates of Protection Europe
ID: 115910
Start date: 2016-03-01, End date: 2021-02-28
Pertussis vaccines have been very successful in reducing the global burden of pertussis-related disease. However, in the last decade there has been a rise in pertussis incidence, particularly in vaccinated adolescents and adults in industrialized countries. The increased...
Programme: H2020-EU.
Record Number: 209454
Last updated on: 2017-03-27
Biomarker Enterprise to Attack DKD
[PROJECT] BEAt-DKD - Biomarker Enterprise to Attack DKD
ID: 115974
Start date: 2016-09-01, End date: 2021-08-31
Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached epidemic dimensions in recent years. Unfortunately, there are no effective means to prevent or cure DKD. Apart from...
Programme: H2020-EU.3.1.7.
Record Number: 209459
Last updated on: 2017-03-27
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
ID: 115881
Start date: 2016-04-01, End date: 2020-03-31
The stated goal of RHAPSODY is to define a molecular taxonomy of type 2 diabetes mellitus (T2D) that will support patient segmentation, inform clinical trial design, and the establishment of regulatory paths for the adoption of novel strategies for diabetes prevention and...
Programme: H2020-EU.
Record Number: 209450
Last updated on: 2017-03-27
Rheuma Tolerance for Cure
[PROJECT] RTCure - Rheuma Tolerance for Cure
ID: 777357
Start date: 2017-09-01, End date: 2022-08-31
In line with IMI2 goals for improved therapies and precision medicine, the aim of this proposal is to prevent and treat RA or its progression by inhibiting maturation/expansion of pathogenic autoimmune responses through immune tolerising treatments of subjects not only in...
Programme: H2020-EU.
Record Number: 211964
Last updated on: 2017-08-29
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen
ID: 115854
Start date: 2014-12-01, End date: 2019-11-30
The overall aim of the EBOVAC programme is to assess the safety and efficacy/effectiveness, if feasible, of a novel prime-boost prophylactic vaccine regimen against Ebola Virus Disease (EVD), which has been 100% effective in preclinical studies. This will be done via phase I...
Programme: H2020-EU.
Record Number: 209452
Last updated on: 2017-03-27
Remote Assessment of Disease and Relapse in Central Nervous System Disorders
ID: 115902
Start date: 2016-04-01, End date: 2021-03-31
Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, adverse events and disease course. This can be inefficient and cumbersome – clinic visits may be too infrequent to identify individuals at...
Programme: H2020-EU.
Record Number: 209453
Last updated on: 2017-05-23
Vaccine lot to Vaccine lot comparison by consistancy testing
ID: 115924
Start date: 2016-03-01, End date: 2021-02-28
Lot release testing of established vaccines relies on using animal models. Many of these models were developed decades ago and reflect the level of product knowledge, production technology and quality management in those days. Current production techniques are optimised...
Programme: H2020-EU.
Record Number: 209456
Last updated on: 2017-07-03
12 3 > 
List retrieved on: 2018-03-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top